articleThe Lancet NeurologyDec 23, 2015Closed access

Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial

ODOrrin DevinskyEDEric D. MarshDJDaniel J. FriedmanEAElizabeth A. ThieleLLLinda Laux

NYU Langone Health · University of Pennsylvania · +11 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

895
total citations
FWCI
67.55
Percentile
100%
References
25
Citations per year

Authors

22

Topics & keywords

Topics
Keywords
  • Cannabidiol
  • Tolerability
  • Medicine
  • Epilepsy
  • Clinical endpoint
  • Adverse effect
  • Randomized controlled trial
  • Internal medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding